INM vs TECH · rev $4.9M vs P/E 65, rev $1.22B
InMed Pharmaceuticals Inc (INM) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
InMed Pharmaceuticals Inc (INM) is a drug manufacturers - specialty & generic company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported INM revenue for 2025-06-30 was $4.9M. Net income was -$8.2M. Revenue was up 7.5% from 2024-06-30 to 2025-06-30. INM currently screens at market cap $5.2M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
INM currently screens at market cap $5.2M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the INM and TECH stock pages for the full models.
Not investment advice.